Lipo-C

• •There is no clinical trial of the Lipo-C / MIC injection itself, so any effect on body weight is unproven and small at best.

• •Most people notice nothing dramatic; reported effects on energy or appetite are subjective and heavily shaped by the accompanying diet and calorie deficit.

• •Any meaningful fat loss comes from the calorie deficit and exercise the injection is paired with, not from the injection alone.

• •If a B12-containing formula is used and you were genuinely deficient, you may notice improved energy; if you were already replete, expect no energy change.

• •Injection-site stinging or redness and mild, short-lived nausea or loose stools are the most common actual experiences.

Beginner Protocol

Intermediate Protocol

Advanced Protocol

Additional Dosage Notes

No clinical trial has ever tested the Lipo-C / MIC injection itself for weight loss, body composition, or fat metabolism. Its evidence base is entirely extrapolated from studies of the individual nutrients, almost all taken orally.

• Choline and methionine (liver fat): Choline is an essential methyl-donor nutrient; deficiency causes hepatic steatosis, and combined methionine-choline deficiency is the classic laboratory model of fatty-liver disease [PMID:23305254][PMID:30681159]. In older adults, adequate dietary choline intake is associated with lower risk of hepatic steatosis, though the relationship is sex- and genotype-dependent [PMID:37513629]. This supports choline's role in liver-fat handling but does not show that extra choline drives body-fat loss in well-nourished people.
• Inositol: In a randomized, double-blind, placebo-controlled trial in women with PCOS, oral inositol improved ovulatory function and produced modest weight loss and leptin reduction versus placebo [PMID:15206484] - a real metabolic signal, but in a specific population and via oral dosing.
• L-carnitine: Meta-analyses of dozens of randomized trials find oral L-carnitine produces a modest average weight reduction of roughly 1.2 to 1.3 kg, with the effect shrinking over time [PMID:32359762][PMID:27335245]. Small, oral, and not specific to injection.

Bottom line: the components have legitimate metabolic roles and, in some cases, modest oral weight-loss signals, but the injectable blend has zero direct clinical evidence. Framed honestly, Lipo-C is best understood as an unproven adjunct to diet and exercise, not a fat-loss treatment in its own right. Research Use Only.

Injection-site pain, stinging, or redness; mild nausea; transient diarrhea or loose stools; headache. Less common: dizziness, allergic reaction, or a transient fishy body odor from high choline intake (trimethylamine). The risk profile of any compounded injectable also depends heavily on sterility and accurate labeling at the compounding source.